예경무
Yea, Kyungmoo학력
- 2004 ~ 2008포항공과대학교 박사
- 2002 ~ 2004포항공과대학교 석사
- 1994 ~ 2000고려대학교 학사
경력
- 2015 ~ 2017The Scripps Research Institute / Assistant Professor
- 2013 ~ 2015Shanghai Tech University / Research Associate Professor
- 2012 ~ 2013(재)스크립스코리아항체연구원 / 선임연구원
- 2009 ~ 2012Stanford Burnham Prebys Medical Discovery Institute / 박사후연구원
- 2008 ~ 2009포항공과대학교 생명공학연구센터 / 박사후연구원
수상실적
- 2025 총장표창 / DGIST
- 2023 총장표창 / DGIST
- 2019 공로상 / DGIST
연구실 소개
- Bio-therapeutics Design Lab
-
New Technologies for Therapeutic AntibodyOur research has managed to create a synthetic immune system in the test tube, as well as demonstrating its preventive and therapeutic potential due to exceeding the natural antibody repertoire the human body can generate.
RESEARCH FOCUS1. Unbiased functional antibody selection2. Agonist antibody selection3. Development of Therapeutic antibodies
Research Interests
Related Keyword
- "Engineered extracellular vesicles with surface FGF21 and enclosed miR-223 for treating metabolic dysfunction-associated steatohepatitis", Cho, Hanchae. (2025-10). Engineered extracellular vesicles with surface FGF21 and enclosed miR-223 for treating metabolic dysfunction-associated steatohepatitis. Biomaterials, 321. doi: 10.1016/j.biomaterials.2025.123321
- "Inflammatory cytokine-primed MSC-derived extracellular vesicles ameliorate acute lung injury via enhanced immunomodulation and alveolar repair", Stem Cell Research & Therapy, v.16, no.1
- "Surface-Engineered Natural Killer Cell-Derived Small Extracellular Vesicles Induce Potent Anti-Tumour Effects in Lung Cancer Cells", Journal of Extracellular Biology, v.4, no.8
- "T-Cell-Derived Extracellular Vesicles with an Antitransferrin Receptor Antibody for Multicancer Targeting", Nano Letters, v.25, no.29, pp.11234 - 11243
- "Modular and Nondisturbing Chimeric Adaptor Protein for Surface Chemistry of Small Extracellular Vesicles", ACS Nano, v.19, no.13, pp.12839 - 12852
연구 뉴스
- 차세대 약물 전달 혁신! DGIST, 엑소좀 활용 정밀 치료제 개발 2025-04-16
- 대사성 난치질환 MASH 치료 위한 차세대 엑소좀 기반 복합 치료 기술 개발 2025-04-16
- A team led by Professor Minseok Kim at DGIST has developed the world’s first bioelectronic medicine source technology to treat senile sarcopenia, a disease for which there is currently no cure. 2023-09-22
- 치료제가 전무한 노인성 근감소증을 치료할 수 있는 전자약 원천기술 세계 최초 개발 2023-08-23
- DGIST Research Team led by Professor Yeh Kyung-Mu Develops Antibodies that Alleviate “Cancer Cachexia” in Cancer Patients 2023-05-17
연구분야
미래유망 신기술(6T)
국가과학기술표준분류